TVTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.75%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $6,179,200.89

Travere Therapeutics Insider Trading History Chart

Travere Therapeutics Share Price & Price History

^$14.92

▲ +0.35 (2.40%)

As of 04/17/2025 05:00 PM ET

Days: 30 | 90 | 365

Travere Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/11/2025	Christopher R. Cline	CFO	Sell	48	$13.14	$630.72	89,990
2/12/2025	William E. Rote	SVP	Sell	5,200	$23.53	$122,356.00	98,519
2/11/2025	Eric M. Dube	CEO	Sell	11,375	$24.04	$273,455.00	419,173
2/11/2025	Peter Heerma	Insider	Sell	3,074	$25.00	$76,850.00	127,634
2/11/2025	Sandra Calvin	CAO	Sell	54,244	$25.00	$1,356,100.00	54,410
2/6/2025	Roy D. Baynes	Director	Sell	10,000	$22.00	$220,000.00	31,000
2/3/2025	Christopher R. Cline	CFO	Sell	5,192	$20.12	$104,463.04	90,038
2/3/2025	Eric M. Dube	CEO	Sell	50,691	$20.21	$1,024,465.11	430,548
2/3/2025	Jula Inrig	Insider	Sell	4,207	$20.12	$84,644.84	85,236
2/3/2025	Sandra Calvin	CAO	Sell	3,348	$20.12	$67,361.76	63,654
2/3/2025	William E. Rote	SVP	Sell	8,951	$19.78	$177,050.78	95,719
1/23/2025	Roy D. Baynes	Director	Sell	16,000	$20.00	$320,000.00	31,000
1/22/2025	Christopher R. Cline	CFO	Sell	865	$18.94	$16,383.10	73,730
1/22/2025	Eric M. Dube	CEO	Sell	10,736	$19.46	$208,922.56	351,239
1/22/2025	Peter Heerma	Insider	Sell	1,584	$18.94	$30,000.96	106,374
1/22/2025	Sandra Calvin	CAO	Sell	925	$18.94	$17,519.50	54,002
1/22/2025	William E. Rote	SVP	Sell	2,437	$19.46	$47,424.02	83,170
1/6/2025	Jula Inrig	Insider	Sell	440	$18.76	$8,254.40	59,443
1/3/2025	Jula Inrig	Insider	Sell	2,066	$19.10	$39,460.60	59,883
12/26/2024	Sandra Calvin	CAO	Sell	15,000	$17.22	$258,300.00	54,927
11/25/2024	Sandra Calvin	CAO	Sell	12,090	$18.30	$221,247.00	54,927
10/4/2024	Gary A Lyons	Director	Sell	40,000	$14.73	$589,200.00	51,000
9/30/2024	Jeffrey A Meckler	Director	Sell	40,000	$14.06	$562,400.00	81,000
9/9/2024	Christopher R. Cline	CFO	Sell	2,490	$11.52	$28,684.80	74,595
9/9/2024	Eric M. Dube	CEO	Sell	21,125	$11.52	$243,360.00	361,975
9/9/2024	Jula Inrig	Insider	Sell	2,191	$11.52	$25,240.32	62,633
9/9/2024	William E. Rote	SVP	Sell	4,387	$11.52	$50,538.24	84,455
9/4/2024	Christopher R. Cline	CFO	Sell	514	$9.51	$4,888.14	70,335
4/11/2024	Christopher R. Cline	CFO	Sell	54	$6.74	$363.96	70,849
2/1/2024	Christopher R. Cline	CFO	Sell	3,818	$8.53	$32,567.54	70,903
2/1/2024	Eric M. Dube	CEO	Sell	19,122	$8.70	$166,361.40	350,600
2/1/2024	Peter Heerma	Insider	Sell	4,195	$8.53	$35,783.35	99,503
2/1/2024	Sandra Calvin	CAO	Sell	2,820	$8.53	$24,054.60	52,017
2/1/2024	William E. Rote	SVP	Sell	4,764	$8.71	$41,494.44	80,720
1/23/2024	Christopher R. Cline	CFO	Sell	853	$9.07	$7,736.71	49,721
1/23/2024	Elizabeth E. Reed	SVP	Sell	2,062	$8.96	$18,475.52	56,034
1/23/2024	Eric M. Dube	CEO	Sell	7,873	$8.96	$70,542.08	234,722
1/23/2024	Peter Heerma	Insider	Sell	1,559	$9.07	$14,140.13	78,698
1/23/2024	Sandra Calvin	CAO	Sell	910	$9.07	$8,253.70	41,337
1/3/2024	Jula Inrig	Insider	Sell	2,069	$9.48	$19,614.12	35,688
10/3/2023	Peter Heerma	Insider	Sell	3,091	$8.25	$25,500.75	80,257
9/5/2023	Christopher R. Cline	CFO	Sell	457	$14.71	$6,722.47	50,574
9/5/2023	Eric M. Dube	CEO	Sell	4,455	$14.71	$65,533.05	242,595
9/5/2023	William E. Rote	SVP	Sell	1,815	$14.71	$26,698.65	61,173
5/10/2023	Christopher R. Cline	CFO	Sell	455	$16.59	$7,548.45	51,031
5/10/2023	Elizabeth E. Reed	SVP	Sell	825	$16.59	$13,686.75	56,611
5/10/2023	Sandra Calvin	CAO	Sell	436	$16.59	$7,233.24	42,369
4/11/2023	Christopher R. Cline	CFO	Sell	47	$21.49	$1,010.03	51,486
2/1/2023	Christopher R. Cline	CFO	Sell	1,588	$21.75	$34,539.00	51,533
2/1/2023	Elizabeth E. Reed	SVP	Sell	2,590	$22.25	$57,627.50	57,436
2/1/2023	Eric M. Dube	CEO	Sell	8,196	$22.25	$182,361.00	237,150
2/1/2023	Peter Heerma	Insider	Sell	1,779	$21.75	$38,693.25	82,069
2/1/2023	Sandra Calvin	CAO	Sell	1,671	$21.75	$36,344.25	43,165
1/24/2023	Christopher R. Cline	CFO	Sell	852	$21.90	$18,658.80	32,871
1/24/2023	Eric M. Dube	CEO	Sell	6,442	$21.50	$138,503.00	147,846
1/24/2023	Peter Heerma	Insider	Sell	1,550	$21.90	$33,945.00	63,598
1/24/2023	Sandra Calvin	CAO	Sell	905	$21.90	$19,819.50	35,028
1/24/2023	William E. Rote	SVP	Sell	2,062	$21.50	$44,333.00	42,376
1/5/2023	Eric M. Dube	CEO	Sell	5,625	$20.75	$116,718.75	154,288
1/4/2023	Jula Inrig	Insider	Sell	2,051	$20.75	$42,558.25	17,949
10/4/2022	Peter Heerma	Insider	Sell	3,042	$25.68	$78,118.56	65,148
9/13/2022	Sandra Calvin	CAO	Sell	349	$28.00	$9,772.00	35,933
5/11/2022	Steve Aselage	Director	Sell	2,575	$21.92	$56,444.00	146,919
5/11/2022	William E. Rote	SVP	Sell	1,563	$21.71	$33,932.73	43,672
5/10/2022	Laura Clague	CFO	Sell	825	$21.51	$17,745.75	37,030
5/10/2022	Sandra Calvin	CAO	Sell	436	$21.51	$9,378.36	36,178

SEC Filings (Institutional Ownership Changes) for Travere Therapeutics (NASDAQ:TVTX)

Institutional Buying and Selling by Quarter

Travere Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/16/2025	Wealth Enhancement Advisory Services LLC	10,139	$0.18M	0.0%	N/A	0.011%
4/15/2025	Assenagon Asset Management S.A.	413,514	$7.41M	0.0%	-22.1%	0.466%
4/8/2025	Rhumbline Advisers	124,550	$2.23M	0.0%	+2.7%	0.140%
4/7/2025	GAMMA Investing LLC	10,501	$0.19M	0.0%	+5,072.9%	0.012%
3/24/2025	Wellington Management Group LLP	33,493	$0.58M	0.0%	N/A	0.038%
3/18/2025	California State Teachers Retirement System	72,192	$1.26M	0.0%	+10.8%	0.081%
2/28/2025	Universal Beteiligungs und Servicegesellschaft mbH	253,622	$4.42M	0.0%	N/A	0.325%
2/19/2025	GF Fund Management CO. LTD.	1,803	$31K	0.0%	N/A	0.002%
2/19/2025	Public Employees Retirement System of Ohio	102,756	$1.79M	0.0%	+102.0%	0.132%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	161,603	$2.82M	0.0%	-1.0%	0.207%
2/17/2025	Voloridge Investment Management LLC	1,007,197	$17.55M	0.1%	+33.6%	1.290%
2/17/2025	Woodline Partners LP	2,114,056	$36.83M	0.2%	-51.3%	2.709%
2/17/2025	Squarepoint Ops LLC	17,556	$0.31M	0.0%	-38.5%	0.022%
2/17/2025	Twinbeech Capital LP	10,169	$0.18M	0.0%	N/A	0.013%
2/17/2025	Two Sigma Advisers LP	967,500	$16.85M	0.0%	+34.3%	1.240%
2/17/2025	Two Sigma Investments LP	693,016	$12.07M	0.0%	+92.5%	0.888%
2/17/2025	Sphera Funds Management LTD.	220,700	$3.85M	0.7%	+29.3%	0.283%
2/17/2025	Rafferty Asset Management LLC	176,425	$3.07M	0.0%	+92.2%	0.226%
2/17/2025	ProShare Advisors LLC	25,347	$0.44M	0.0%	+37.4%	0.032%
2/17/2025	Parkman Healthcare Partners LLC	1,117,792	$19.47M	2.6%	+2.9%	1.432%
2/17/2025	Man Group plc	88,241	$1.54M	0.0%	+246.8%	0.113%
2/17/2025	Nuveen Asset Management LLC	1,743,190	$30.37M	0.0%	-4.9%	2.233%
2/17/2025	Millennium Management LLC	626,056	$10.91M	0.0%	+446.2%	0.802%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	49,946	$0.87M	0.0%	+23.4%	0.064%
2/17/2025	Integral Health Asset Management LLC	100,000	$1.74M	0.1%	N/A	0.128%
2/17/2025	J. Goldman & Co LP	181,174	$3.16M	0.1%	N/A	0.232%
2/17/2025	Jacobs Levy Equity Management Inc.	2,174,213	$37.88M	0.1%	+36.7%	2.786%
2/17/2025	Gen Wealth Partners Inc	4,210	$73K	0.0%	N/A	0.005%
2/17/2025	Deutsche Bank AG	532,031	$9.27M	0.0%	-24.5%	0.682%
2/17/2025	Driehaus Capital Management LLC	2,217,975	$38.64M	0.3%	+608.1%	2.842%
2/17/2025	Crestline Management LP	185,840	$3.24M	0.1%	+53.9%	0.238%
2/17/2025	Brevan Howard Capital Management LP	30,953	$0.54M	0.0%	-49.8%	0.040%
2/17/2025	Bellevue Group AG	23,100	$0.40M	0.0%	-25.5%	0.030%
2/17/2025	BNP Paribas Financial Markets	1,209,810	$21.08M	0.0%	N/A	1.550%
2/17/2025	Ameriprise Financial Inc.	285,350	$4.97M	0.0%	+132.6%	0.366%
2/17/2025	Algert Global LLC	16,167	$0.28M	0.0%	N/A	0.021%
2/14/2025	RA Capital Management L.P.	1,150,000	$20.03M	0.3%	N/A	1.473%
2/14/2025	Freestone Grove Partners LP	25,521	$0.45M	0.0%	N/A	0.033%
2/14/2025	PDT Partners LLC	247,109	$4.31M	0.4%	-6.5%	0.317%
2/14/2025	Schonfeld Strategic Advisors LLC	23,000	$0.40M	0.0%	-86.9%	0.029%
2/14/2025	AQR Capital Management LLC	424,024	$7.39M	0.0%	+117.8%	0.543%
2/14/2025	Emerald Mutual Fund Advisers Trust	1,101,774	$19.19M	1.2%	-7.1%	1.412%
2/14/2025	Northern Trust Corp	754,395	$13.14M	0.0%	+11.3%	0.967%
2/14/2025	The Manufacturers Life Insurance Company	27,338	$0.48M	0.0%	-41.9%	0.035%
2/14/2025	Tudor Investment Corp ET AL	43,213	$0.75M	0.0%	+13.3%	0.055%
2/14/2025	Quarry LP	12,000	$0.21M	0.0%	+60.0%	0.015%
2/14/2025	Aquatic Capital Management LLC	31,967	$0.56M	0.0%	N/A	0.041%
2/14/2025	Virtus ETF Advisers LLC	19,523	$0.34M	0.1%	-57.1%	0.025%
2/14/2025	Adage Capital Partners GP L.L.C.	376,800	$6.56M	0.0%	-5.8%	0.483%
2/14/2025	Syon Capital LLC	15,435	$0.27M	0.0%	N/A	0.020%
2/14/2025	Price T Rowe Associates Inc. MD	39,604	$0.69M	0.0%	-85.9%	0.051%
2/14/2025	Silverarc Capital Management LLC	277,365	$4.83M	1.1%	N/A	0.355%
2/14/2025	Eversept Partners LP	490,296	$8.54M	0.8%	-43.6%	0.628%
2/14/2025	Hsbc Holdings PLC	27,835	$0.49M	0.0%	-33.4%	0.036%
2/14/2025	Rock Springs Capital Management LP	4,973,649	$86.64M	3.3%	+6.2%	6.372%
2/14/2025	Tower Research Capital LLC TRC	21,367	$0.37M	0.0%	+211.2%	0.027%
2/14/2025	MetLife Investment Management LLC	44,711	$0.78M	0.0%	+8.7%	0.057%
2/13/2025	CANADA LIFE ASSURANCE Co	23,318	$0.41M	0.0%	+237.8%	0.030%
2/13/2025	Jump Financial LLC	76,842	$1.34M	0.0%	-72.2%	0.098%
2/13/2025	Walleye Capital LLC	427,230	$7.44M	0.0%	-12.5%	0.547%
2/13/2025	XTX Topco Ltd	29,133	$0.51M	0.0%	+105.1%	0.037%
2/13/2025	Barclays PLC	396,570	$6.91M	0.0%	+135.0%	0.508%
2/13/2025	Summit Investment Advisors Inc.	7,905	$0.14M	0.1%	+9.2%	0.010%
2/13/2025	Sterling Capital Management LLC	2,361	$41K	0.0%	+859.8%	0.003%
2/13/2025	F M Investments LLC	111,158	$1.94M	0.1%	N/A	0.142%
2/13/2025	Renaissance Technologies LLC	2,409,514	$41.97M	0.1%	+28.5%	3.087%
2/13/2025	Legal & General Group Plc	78,963	$1.38M	0.0%	-13.2%	0.101%
2/13/2025	Invesco Ltd.	858,942	$14.96M	0.0%	+135.2%	1.101%
2/13/2025	Federated Hermes Inc.	668,315	$11.64M	0.0%	+7.1%	0.856%
2/12/2025	Knott David M Jr	228,000	$3.97M	1.4%	-11.7%	0.292%
2/12/2025	Trexquant Investment LP	280,217	$4.88M	0.1%	-21.4%	0.359%
2/12/2025	Headlands Technologies LLC	4,048	$71K	0.0%	-70.4%	0.005%
2/12/2025	Geode Capital Management LLC	1,842,301	$32.10M	0.0%	+6.4%	2.360%
2/12/2025	Franklin Resources Inc.	36,238	$0.63M	0.0%	N/A	0.046%
2/12/2025	Wellington Management Group LLP	33,493	$0.58M	0.0%	N/A	0.043%
2/12/2025	Schroder Investment Management Group	417,253	$7.23M	0.0%	-38.4%	0.535%
2/12/2025	Pictet Asset Management Holding SA	709,390	$12.36M	0.0%	-7.0%	0.909%
2/12/2025	Norges Bank	71,000	$1.24M	0.0%	N/A	0.091%
2/11/2025	EntryPoint Capital LLC	20,600	$0.36M	0.2%	N/A	0.026%
2/11/2025	Prudential Financial Inc.	969,141	$16.88M	0.0%	+60.5%	1.242%
2/11/2025	Corebridge Financial Inc.	37,565	$0.65M	0.0%	-4.7%	0.048%
2/11/2025	Emerald Advisers LLC	2,125,744	$37.03M	1.4%	+8.4%	2.724%
2/11/2025	Vanguard Group Inc.	6,742,165	$117.45M	0.0%	-2.3%	8.638%
2/11/2025	Fox Run Management L.L.C.	25,708	$0.45M	0.1%	N/A	0.033%
2/11/2025	KLP Kapitalforvaltning AS	15,000	$0.26M	0.0%	N/A	0.019%
2/11/2025	Semanteon Capital Management LP	84,783	$1.48M	0.8%	+131.0%	0.109%
2/11/2025	Teacher Retirement System of Texas	22,935	$0.40M	0.0%	+33.3%	0.029%
2/10/2025	Swiss National Bank	151,900	$2.65M	0.0%	+12.8%	0.195%
2/10/2025	Connor Clark & Lunn Investment Management Ltd.	426,726	$7.43M	0.0%	-18.8%	0.547%
2/7/2025	E Fund Management Co. Ltd.	12,481	$0.22M	0.0%	N/A	0.016%
2/6/2025	Arizona State Retirement System	22,396	$0.39M	0.0%	+13.5%	0.029%
2/6/2025	Aigen Investment Management LP	19,072	$0.33M	0.1%	+56.6%	0.024%
2/6/2025	Victory Capital Management Inc.	10,463	$0.18M	0.0%	N/A	0.013%
2/6/2025	Charles Schwab Investment Management Inc.	661,603	$11.53M	0.0%	+16.6%	0.848%
2/5/2025	US Bancorp DE	31,795	$0.55M	0.0%	+323.4%	0.041%
2/4/2025	Los Angeles Capital Management LLC	15,996	$0.28M	0.0%	-42.8%	0.020%
2/4/2025	Bank of New York Mellon Corp	216,863	$3.78M	0.0%	+3.6%	0.278%
2/4/2025	Impax Asset Management Group plc	300,000	$5.23M	0.0%	N/A	0.384%
2/3/2025	Ieq Capital LLC	20,749	$0.36M	0.0%	N/A	0.027%
1/31/2025	Rice Hall James & Associates LLC	92,658	$1.61M	0.1%	-2.2%	0.119%

Data available starting January 2016

Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases. Its products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pathways in the disease progression of IgA Nephropathy (endothelin 1 and angiotensin-II); and Thiola and Thiola EC (tiopronin tablets) for the treatment of cystinuria, a rare genetic cystine transport disorder that causes high cystine levels in the urine and the formation of recurring kidney stones. The company's clinical-stage programs consist of Sparsentan, a novel investigational product candidate, which has been granted Orphan Drug Designation for the treatment of focal segmental glomerulosclerosis in the U.S. and Europe; and Pegtibatinase (TVT-058), a novel investigational human enzyme replacement candidate being evaluated for the treatment of classical homocystinuria. It has a cooperative research and development agreement with National Institutes of Health's National Center for Advancing Translational Sciences and Alagille Syndrome Alliance for the identification of potential small molecule therapeutics for Alagille syndrome. The company was formerly known as Retrophin, Inc. and changed its name to Travere Therapeutics, Inc. in November 2020. Travere Therapeutics, Inc. was incorporated in 2008 and is headquartered in San Diego, California.

Today's Range

Now: $14.92

$14.56

$15.00

50 Day Range

MA: $19.06

$13.49

$23.75

52 Week Range

Now: $14.92

$5.12

$25.29

Volume

1,101,182 shs

Average Volume

1,518,383 shs

Market Capitalization

$1.32 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.84

Who are the company insiders with the largest holdings of Travere Therapeutics?: Travere Therapeutics' top insider investors include:
Eric M Dube (CEO)
Peter Heerma (Insider)
William E Rote (SVP)
Christopher R Cline (CFO)
Jula Inrig (Insider)
Jeffrey A Meckler (Director)
Sandra Calvin (CAO)
Elizabeth E Reed (SVP)
Gary A Lyons (Director)
Roy D Baynes (Director)
Learn More about top insider investors at Travere Therapeutics.
Who are the major institutional investors of Travere Therapeutics?: Travere Therapeutics' top institutional shareholders include:
Assenagon Asset Management S.A. — 0.47%
Rhumbline Advisers — 0.14%
GAMMA Investing LLC — 0.01%
Wealth Enhancement Advisory Services LLC — 0.01%
Learn More about top institutional investors of Travere Therapeutics stock.
Which institutional investors are selling Travere Therapeutics stock?: In the previous quarter, TVTX stock was sold by these institutional investors:
Assenagon Asset Management S.A.
In the previous year, company insiders that have sold Travere Therapeutics company stock include:
Eric M Dube (CEO)
Peter Heerma (Insider)
William E Rote (SVP)
Christopher R Cline (CFO)
Jula Inrig (Insider)
Jeffrey A Meckler (Director)
Sandra Calvin (CAO)
Elizabeth E Reed (SVP)
Gary A Lyons (Director)
Learn More investors selling Travere Therapeutics stock.
Which institutional investors are buying Travere Therapeutics stock?: In the last quarter, TVTX stock was bought by institutional investors including:
GAMMA Investing LLC
Wealth Enhancement Advisory Services LLC
Rhumbline Advisers